Apellis Pharmaceuticals’ (APLS) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a research report released on Thursday morning,Benzinga reports. HC Wainwright currently has a $57.00 target price on the stock. Several other equities research analysts have also recently weighed in on APLS. Royal Bank of Canada restated a “sector perform” […]
HC Wainwright reiterated their buy rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a research report released on Thursday morning,Benzinga reports. HC Wainwright currently has a $57.00 target price on the stock. Several other equities research analysts have also recently weighed in on APLS. Royal Bank of Canada restated a “sector perform” […]
